Tooth counts do not predict bone mineral density in early postmenopausal Caucasian women. EPIC study group.
BACKGROUND
It has been suggested that poor dental status may be a suitable criterion for bone densitometry referral in early postmenopausal women. We evaluated this hypothesis in a cohort of 1365 Caucasian women aged between 45 and 59 years, who were enrolled into an international multi-centre trial.


METHODS
Subjects were recruited at four study centres, using population-based techniques. Bone mineral density (BMD) at the lumbar spine and proximal femur was measured by dual energy x-ray absorptiometry (DXA) (Hologic QDR 2000). A full physical examination was performed including a tooth count.


RESULTS
Baseline tooth counts ranged from 0 to 32 (median 26): 84 (6%) subjects were edentulous. When classified according to the WHO criteria 445 (33%) of the subjects were osteoporotic at one or more of the skeletal sites analysed; 694 (51%) were osteopenic, and 226 (16%) were normal. Adjusting for confounding variables, there was no significant correlation between tooth count and BMD at any skeletal site. Subjects were divided into tertiles of tooth count, and chi2 tests used to compare the two 'extreme' groups against the WHO criteria for BMD. At each of the six BMD regions the proportion of subjects with normal, osteopenic or osteoporotic BMD was similar for both tertiles.


CONCLUSIONS
We found no relationship between tooth count and BMD in early postmenopausal women. This may be because in younger women dental status is a reflection more of dietary habits and past dental surgery than of age-related bone loss. Tooth counts therefore cannot be used to identify individuals at risk of osteoporosis.
Earnshaw
S A
SA
City Hospital, Nottingham, UK.
Keating
N
N
Hosking
D J
DJ
Chilvers
C E
CE
Ravn
P
P
McClung
M
M
Wasnich
R D
RD
D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D015331:Cohort Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D017698:Postmenopause / Q000187:drug effects / Q000502:physiology*; D018570:Risk Assessment; D016388:Tooth Loss / Q000503:physiopathology*; D044465:White People
D019386:Alendronate